EP3417862
ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.7.2013EP published:
5.5.2021EP application number:
18186075.0
EPO information:
European Patent Register
Max expiry date:
28.7.2033
Title:
ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
Timeline
Today
29.7.2013EP application
5.5.2021EP Publication
Owner
Name:
Neurodyn Life Sciences Inc.Address:
Suite 508 NRC-INH 550 University Ave, Charlottetown C1A 4P3, CA
Inventor
Name:
Maelicke, AlfredAddress:
deceased, DE
Priority
Number:
201261676348 PDate:
27.7.2012Country:
US
Number:
12178187Date:
27.7.2012Country:
EP
Classification
Categories:
A61K 31/55, A61K 31/00, A61K 9/00, A61K 9/14, A61P 25/28, A61K 9/107